Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 5/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.43 |
| ▸ | TP53 | P04637 | 2/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.43 |
| ▸ | RXRA | P19793 | 1/20 | 0.36 |
| ▸ | RXRB | P28702 | 1/20 | 0.36 |
| ▸ | RXRG | P48443 | 1/20 | 0.36 |
| ▸ | BAX | Q07812 | 1/20 | 0.35 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.35 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.33 |
| ▸ | MEN1 | O00255 | 3/20 | 0.33 |
| ▸ | CNR2 | P34972 | 1/20 | 0.33 |
| ▸ | PPARG | P37231 | 1/20 | 0.33 |
| ▸ | NCOA2 | Q15596 | 1/20 | 0.33 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8540288 | 0.84 | DDB1 (0.36) | MAPTMAPK1TP53ALDH1A1LMNA | |
| SCHEMBL27241687 | 0.81 | CYP4F2 (0.36) | RXRARXRBRXRGCNR2 | |
| SCHEMBL30182911 | 0.79 | MAPT (0.38) | MAPTMAPK1TP53ALDH1A1LMNA | |
| SCHEMBL5026596 | 0.77 | CYP1A2 (0.41) | ALDH1A1NPSR1SIGMAR1KMT2AMEN1 | |
| SCHEMBL19051094 | 0.77 | RXRA (0.38) | MAPTLMNARXRARXRBRXRG | |
| SCHEMBL24268653 | 0.76 | MAPT (0.37) | MAPTMAPK1TP53ALDH1A1LMNA | |
| SCHEMBL767404 | 0.76 | CYP4F2 (0.39) | MAPTMAPK1TP53ALDH1A1LMNA | |
| SCHEMBL18281904 | 0.76 | GAA (0.41) | MAPTMAPK1TP53ALDH1A1LMNA | |
| SCHEMBL30615352 | 0.76 | MAPT (0.37) | MAPTMAPK1TP53ALDH1A1LMNA | |
| SCHEMBL15744178 | 0.76 | CYP4F2 (0.39) | MAPTMAPK1TP53ALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240190901-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2024-06-13 | — | — | US | disclosed |
| US-11818948-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2023-11-14 | — | — | US | disclosed |
| US-11818948-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2023-11-14 | — | — | US | disclosed |
| US-20170186970-A1 | Organic Electroluminescent Materials and Devices | UNIVERSAL DISPLAY CORPORATION | 2017-06-29 | — | — | US | disclosed |
| US-20170186970-A1 | Organic Electroluminescent Materials and Devices | UNIVERSAL DISPLAY CORPORATION | 2017-06-29 | — | — | US | disclosed |
| EP-2356168-B1 | AMINOBENZENE COMPOSITIONS AND RELATED DEVICES AND METHODS | SOLVAY USA INC (US) | 2015-05-27 | — | — | EP | disclosed |
| EP-2356168-B1 | AMINOBENZENE COMPOSITIONS AND RELATED DEVICES AND METHODS | SOLVAY USA INC (US) | 2015-05-27 | — | — | EP | disclosed |
| US-20130075670-A1 | AMINOBENZENE COMPOSITIONS AND RELATED DEVICES AND METHODS | PLEXTRONICS, INC. (US) | 2013-03-28 | — | — | US | disclosed |
| US-20130075670-A1 | AMINOBENZENE COMPOSITIONS AND RELATED DEVICES AND METHODS | PLEXTRONICS, INC. (US) | 2013-03-28 | — | — | US | disclosed |
| US-20130075670-A1 | AMINOBENZENE COMPOSITIONS AND RELATED DEVICES AND METHODS | PLEXTRONICS, INC. (US) | 2013-03-28 | — | — | US | disclosed |
| US-8283002-B2 | Aminobenzene compositions and related devices and methods | PLEXTRONICS, INC. (US) | 2012-10-09 | — | — | US | disclosed |
| US-8283002-B2 | Aminobenzene compositions and related devices and methods | PLEXTRONICS, INC. (US) | 2012-10-09 | — | — | US | disclosed |
| US-8283002-B2 | Aminobenzene compositions and related devices and methods | PLEXTRONICS, INC. (US) | 2012-10-09 | — | — | US | disclosed |
| EP-2356168-A2 | AMINOBENZENE COMPOSITIONS AND RELATED DEVICES AND METHODS | Plextronics, Inc. (US) | 2011-08-17 | — | — | EP | disclosed |
| US-20100292399-A1 | AMINOBENZENE COMPOSITIONS AND RELATED DEVICES AND METHODS | PLEXTRONICS, INC. | 2010-11-18 | — | — | US | disclosed |
| US-20100292399-A1 | AMINOBENZENE COMPOSITIONS AND RELATED DEVICES AND METHODS | PLEXTRONICS, INC. | 2010-11-18 | — | — | US | disclosed |
| US-20100292399-A1 | AMINOBENZENE COMPOSITIONS AND RELATED DEVICES AND METHODS | PLEXTRONICS, INC. | 2010-11-18 | — | — | US | disclosed |
| WO-2010059646-A2 | AMINOBENZENE COMPOSITIONS AND RELATED DEVICES AND METHODS | PLEXTRONICS, INC. (US) | 2010-05-27 | — | — | WO | disclosed |
| WO-2010059646-A2 | AMINOBENZENE COMPOSITIONS AND RELATED DEVICES AND METHODS | PLEXTRONICS, INC. (US) | 2010-05-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240190901-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OCIAD2, OCIAD1, ODC1 | MAPT 477/4885MAPK1 3088/4885TP53 3080/4885 |
| US-20130075670-A1 | AMINOBENZENE COMPOSITIONS AND RELATED DEVICES AND METHODS | HLA-B, AAAS, SLCO2B1 | MAPT 322/4885MAPK1 826/4885TP53 691/4885 |
| US-20170186970-A1 | Organic Electroluminescent Materials and Devices | SLCO4C1, SLC29A1, SLC29A2 | MAPT 3388/4885MAPK1 2012/4885TP53 2308/4885 |
| US-11818948-B2 | Organic electroluminescent materials and devices | SLCO4C1, SLC29A1, SLC29A2 | MAPT 3388/4885MAPK1 2012/4885TP53 2308/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.